BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25692890)

  • 1. Oral propranolol for parotid infantile hemangiomas.
    Li G; Xu DP; Sun HL; Cheng C; Liu ZM; Xi SL; Wang XK
    J Craniofac Surg; 2015 Mar; 26(2):438-40. PubMed ID: 25692890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of infantile parotid hemangioma with propranolol].
    Liu XJ; Qin ZP; Tai MZ; Li KL; Ge CX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):292-4. PubMed ID: 20654246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
    Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of propranolol in the treatment of parotid hemangioma.
    Morais P; Magina S; Mateus M; Trindade E; Jesus JM; Azevedo F
    Cutan Ocul Toxicol; 2011 Sep; 30(3):245-8. PubMed ID: 21338243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
    MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
    J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of propranolol for parotid hemangioma.
    Chang L; Jin Y; Lv D; Ying H; Wang T; Qiu Y; Ma G; Chen H; Yu W; Yang X; Lin X
    Head Neck; 2016 Apr; 38 Suppl 1():E1730-6. PubMed ID: 26676449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas.
    Tong S; Xu DP; Liu ZM; Du Y; Wang XK
    Oncol Lett; 2016 Sep; 12(3):1806-1810. PubMed ID: 27588127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas.
    Wang Y; Zhang X; Yang Y; Zhang J; Yang Y; Lu Y
    Indian J Pediatr; 2017 Jun; 84(6):425-429. PubMed ID: 28194699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population.
    Harris J; Phillips JD
    Ear Nose Throat J; 2021 Jun; 100(5):NP242-NP245. PubMed ID: 31565986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
    Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
    Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of beta blockers--a new perspective in therapy of infantile hemangiomas of the head and neck area].
    Eivazi B; Teymoortash A; Stiller S; Cremer H; Werner JA
    Laryngorhinootologie; 2010 Apr; 89(4):230-1. PubMed ID: 19728258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.